drugset / Trial / NCT03225352
A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets
RandomizedCrossoverOpen-labelOther
Summary
The aim of this study is to assess disintegration of the new Aspirin disintegrating tablets
Timeline
- Start
- 2017-08-07
- Primary completion
- 2017-10-07
- Completion
- 2017-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 500 mg | — |
| Subject | Aspirin | Small molecule | 1000 mg | — |
| Subject | Ibuprofen | Small molecule | 400 mg | — |
Indications
No indication recorded.